Evaluation of immune response in young patients with sarcoma
treated by dendritic cell-based immunotherapy

a 2019

Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy

FĚDOROVÁ, Lenka, Lenka ZDRAŽILOVÁ DUBSKÁ, I. SELINGEROVA, Kateřina PILÁTOVÁ, Peter MÚDRY et. al.

Basic information

Original name

Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy

Authors

FĚDOROVÁ, Lenka (203 Czech Republic), Lenka ZDRAŽILOVÁ DUBSKÁ (203 Czech Republic, guarantor, belonging to the institution), I. SELINGEROVA (203 Czech Republic), Kateřina PILÁTOVÁ (203 Czech Republic, belonging to the institution), Peter MÚDRY (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution), Regina DEMLOVÁ (203 Czech Republic, belonging to the institution) and Dalibor VALÍK (203 Czech Republic, belonging to the institution)

Edition

ESMO Immuno-Oncology Congress 2019 11–14 December 2019, Geneva, Switzerland, 2019

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30204 Oncology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

RIV identification code

RIV/00216224:14110/19:00113594

Organization unit

Faculty of Medicine

UT WoS

000506799900043

Keywords in English

sarcoma; dendritic cell-based immunotherapy

Abstract

V originále

Individually prepared immunotherapy (ITx) based on autologous dendritic cells (DCs) represents a new possibility in modern advanced anti-cancer treatment. As an extended evaluation of DC-based medicinal product in an academic phase I/II clinical trial for children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors (EudraCT 2014-003388-39), we performed the examination of T-cell stimulatory properties and detailed peripheral blood immunomonitoring.

Links

LM2015090, research and development project

Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)

Investor: Ministry of Education, Youth and Sports of the CR

Citovat

FĚDOROVÁ, Lenka, Lenka ZDRAŽILOVÁ DUBSKÁ, I. SELINGEROVA, Kateřina PILÁTOVÁ, Peter MÚDRY, Jaroslav ŠTĚRBA, Regina DEMLOVÁ and Dalibor VALÍK. Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy. In ESMO Immuno-Oncology Congress 2019 11–14 December 2019, Geneva, Switzerland. 2019.

@proceedings{1643639,
   author = {Fědorová, Lenka and Zdražilová Dubská, Lenka and Selingerova, I. and Pilátová, Kateřina and Múdry, Peter and Štěrba, Jaroslav and Demlová, Regina and Valík, Dalibor},
   booktitle = {ESMO Immuno-Oncology Congress 2019 11–14 December 2019, Geneva, Switzerland},
   keywords = {sarcoma; dendritic cell-based immunotherapy},
   language = {eng},
   title = {Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy},
   url = {https://www.annalsofoncology.org/article/S0923-7534(20)34423-9/fulltext},
   year = {2019}
}

TY  - CONF
ID  - 1643639
AU  - Fědorová, Lenka - Zdražilová Dubská, Lenka - Selingerova, I. - Pilátová, Kateřina - Múdry, Peter - Štěrba, Jaroslav - Demlová, Regina - Valík, Dalibor
PY  - 2019
TI  - Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy
KW  - sarcoma
KW  - dendritic cell-based immunotherapy
UR  - https://www.annalsofoncology.org/article/S0923-7534(20)34423-9/fulltext
L2  - https://www.annalsofoncology.org/article/S0923-7534(20)34423-9/fulltext
N2  - Individually prepared immunotherapy (ITx) based on autologous dendritic cells (DCs) represents a new possibility in modern advanced anti-cancer treatment. As an extended evaluation of DC-based medicinal product in an academic phase I/II clinical trial for children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors (EudraCT 2014-003388-39), we performed the examination of T-cell stimulatory properties and detailed peripheral blood immunomonitoring.
ER  -

FĚDOROVÁ, Lenka, Lenka ZDRAŽILOVÁ DUBSKÁ, I. SELINGEROVA, Kateřina PILÁTOVÁ, Peter MÚDRY, Jaroslav ŠTĚRBA, Regina DEMLOVÁ and Dalibor VALÍK. Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy. In \textit{ESMO Immuno-Oncology Congress 2019 11–14 December 2019, Geneva, Switzerland}. 2019.

Detailed Information on Publication Record